NCT04446416 2026-04-09
Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients
NaviFUS Corporation
Phase NA Completed
Clinical Trials
8 trialsNCT05284643 2025-08-01
Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma
University of Miami
Phase NA Recruiting
NCT05410301 2023-04-21
Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma
University of Iowa
Phase NA Withdrawn
NCT05811793 2023-04-13
Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.
Second Affiliated Hospital of Nanchang University
Phase NA Unknown
NCT02076152 2021-07-30
FMISO PET Study of Glioblastoma
Massachusetts General Hospital
Phase NA Completed
NCT01836536 2017-03-01
AVA-CELL
Center Eugene Marquis
Phase NA Completed
NCT02841332 2016-12-20
IMAGLIO
University Hospital, Toulouse
Phase NA Terminated
NCT01939574 2016-01-21
A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma
Shandong Cancer Hospital and Institute
Phase NA Unknown